Sigma Of Australia Gets Shareholder Approval To Sell To Aspen
This article was originally published in PharmAsia News
Executive Summary
Shareholders of Australia's Sigma Pharmaceuticals gave their approval to the firm being acquired by Aspen Pharmacare Holdings of South Africa